振荡性脑活动与弥漫性胶质瘤患者神经连接蛋白-3表达相关并预测无进展生存期
该研究纳入24例新诊断弥漫性胶质瘤患者,术前进行脑磁图检查并随后切除肿瘤,以宽带功率(0.5-48 Hz)近似振荡性脑活动,用免疫组化半定量评估肿瘤组织神经连接蛋白-3(NLGN3)表达。结果显示NLGN3低表达者全局振荡性脑活动水平较低(P < 0.001),较低的瘤周(HR 2.17,P = 0.008)和全局振荡性脑活动(HR 2.10,P = 0.008)预测更长的无进展生存期(PFS)。
要点
- NLGN3低表达患者的全局振荡性脑活动水平低于NLGN3较高表达患者(P < 0.001)。
- 较低的瘤周振荡性脑活动预测更长的PFS(HR 2.17,P = 0.008)。
- 较低的全局振荡性脑活动预测更长的PFS(HR 2.10,P = 0.008)。
核心结论
- 较低的瘤周和全局振荡性脑活动与较低的NLGN3表达及更长的PFS相关,印证了临床前研究。
研究设计与样本
- 研究纳入24例新诊断弥漫性胶质瘤患者,行脑磁图检查后接受肿瘤切除术。
- 以脑磁图宽带功率(0.5-48 Hz)近似振荡性脑活动,用免疫组化半定量评估肿瘤组织NLGN3表达。
- 采用Kruskal-Wallis检验比较不同NLGN3表达水平间的瘤周和全局振荡性脑活动,用Cox比例风险分析评估振荡性脑活动对PFS的预测价值。
主要发现
- NLGN3低表达患者的全局振荡性脑活动水平低于NLGN3较高表达患者(P < 0.001)。
- 较低的瘤周振荡性脑活动预测更长的PFS(HR 2.17,P = 0.008)。
- 较低的全局振荡性脑活动预测更长的PFS(HR 2.10,P = 0.008)。
临床怎么用
- 作者认为该研究凸显了宏观测量的脑活动与胶质瘤进展之间的重要相互作用,并可能为弥漫性胶质瘤患者带来新的治疗干预。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Diffuse gliomas have local and global effects on neurophysiological brain functioning, which are often seen as 'passive' consequences of the tumor. However, seminal preclinical work has shown a prominent role for neuronal activity in glioma growth: mediated by neuroligin-3 (NLGN3), increased neuronal activity causes faster glioma growth. It is unclear whether the same holds true in patients. Here, we investigate whether lower levels of oscillatory brain activity relate to lower NLGN3 expression and predict longer progression free survival (PFS) in diffuse glioma patients. METHODS: Twenty-four newly diagnosed patients with diffuse glioma underwent magnetoencephalography and subsequent tumor resection. Oscillatory brain activity was approximated by calculating broadband power (0.5-48 Hz) of the magnetoencephalography. NLGN3 expression in glioma tissue was semi-quantitatively assessed by immunohistochemistry. Peritumor and global oscillatory brain activity was then compared between different levels of NLGN3 expression with Kruskal-Wallis tests. Cox proportional hazards analyses were performed to estimate the predictive value of oscillatory brain activity for PFS. RESULTS: Patients with low expression of NLGN3 had lower levels of global oscillatory brain activity than patients with higher NLGN3 expression (P < 0.001). Moreover, lower peritumor (hazard ratio 2.17, P = 0.008) and global oscillatory brain activity (hazard ratio 2.10, P = 0.008) predicted longer PFS. CONCLUSIONS: Lower levels of peritumor and global oscillatory brain activity are related to lower NLGN3 expression and longer PFS, corroborating preclinical research. This study highlights the important interplay between macroscopically measured brain activity and glioma progression, and may lead to new therapeutic interventions in diffuse glioma patients.
引用
- Derks J, Wesseling P, Carbo EWS, et al. Oscillatory brain activity associates with neuroligin-3 expression and predicts progression free survival in patients with diffuse glioma. J Neurooncol. 2018. PMID: 30094719. doi:10.1007/s11060-018-2967-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。